Announcements Trials

Browse Landscape

Status

Unknown 3 Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Rectal Neoplasms 1 Pancreatic Cancer Resectable 1 Ovarian Carcinosarcoma 1 Neoplasms 1 Liver Neoplasms 1 Immune-related Adverse Event 1 Esophageal Neoplasms 1 Early Hormone Receptor-positive Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

Blood Specimen Collection 38 pembrolizumab 36 Bevacizumab 22 Surveys and Questionnaires 18 Standard of Care 18 Radiotherapy 18 Exercise 17 Carboplatin 16 Nivolumab 15 atezolizumab 14 Cisplatin 14 Drug Therapy 13 Paclitaxel 12 Fluorouracil 12 Cyclophosphamide 12 Cetuximab 12 Trastuzumab 10 Leucovorin 10 Docetaxel 10 Dexamethasone 10 Pemetrexed 9 Oxaliplatin 9 Biopsy 9 pertuzumab 8 olaparib 8 Temozolomide 8 Panitumumab 8 Observation 8 Irinotecan 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Antineoplastic Agents × Clear all

NCT05467189 2022-07-20

Antineoplastic Drugs in Elderly Patients

Shandong University

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡